According to Enzo Biochem's latest financial reports the company's current EPS (TTM) is -โน80.54. In 2022 the company made an earnings per share (EPS) of -โน47.13 a decrease over its 2021 EPS that were of โน8.57.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน76.45 | 62.23% |
2022 | -โน47.13 | -650% |
2021 | โน8.57 | -123.26% |
2020 | -โน36.84 | -2250% |
2019 | โน1.71 | -106.06% |
2018 | -โน28.28 | 1018.34% |
2017 | -โน2.53 | -103.47% |
2016 | โน72.83 | 507.14% |
2015 | โน12.00 | -156% |
2014 | -โน21.42 | -43.18% |
2013 | -โน37.70 | -55.56% |
2012 | -โน84.83 | 130.23% |
2011 | -โน36.84 | -24.56% |
2010 | -โน48.84 | 14% |
2009 | -โน42.84 | 16.28% |
2008 | -โน36.84 | 19.44% |
2007 | -โน30.85 | -16.28% |
2006 | -โน36.84 | 79.17% |
2005 | -โน20.56 | -1300% |
2004 | โน1.71 | -263.03% |
2003 | -โน1.05 | -104.34% |
2002 | โน24.21 | 28.8% |
2001 | โน18.79 | -2.16% |
2000 | โน19.21 | -6.51% |
1999 | โน20.55 | 93.68% |
1998 | โน10.61 | 85.84% |
1997 | โน5.71 | -122.52% |
1996 | -โน25.35 |